6515--3D Prostate Cartography and Biopsy System

The U.S. Department of Veterans Affairs, through the Network Contracting Office 21, is conducting market research to identify qualified vendors capable of supplying a 3D Prostate Cartography and Biopsy System for the VA San Francisco Health Care System. This effort is not a solicitation for bids or proposals but rather a sources sought notice aimed at assessing industry capabilities, determining potential sources, and informing future procurement planning. The required system must be FDA-approved and meet the salient characteristics outlined in the associated item worksheet, with all offerings considered brand-name or equal. Responses must include a capability statement, business size and socio-economic status classification—such as small, small disadvantaged, woman-owned, veteran-owned, or large business—including UEI number, SAM and DSBS registration status, and confirmation of GSA Federal Supply Schedule coverage if applicable. Pricing, past performance with federal or private entities, and documentation of OEM authorization must be provided to support qualification. Submissions are due by 10:00 AM Mountain Time on Thursday, July 16, 2026, and must be sent via email to the designated contracting officer. Responses must clearly indicate the subject line as specified and include all required elements: statement of capability, GSA Schedule information, UEI number, business size classification, and socio-economic status details. The government will not compensate respondents for any costs incurred in preparing responses, nor will this notice obligate it to issue a solicitation or award a contract. If a solicitation is later released, it will be posted on GSA eBuy, and only vendors holding an active GSA Schedule with the correct SIN will be eligible to respond. Vendors must be registered in SAM to qualify for any future award, and those seeking SDVOSB or VOSB set-aside status must also be verified in the SBA’s Dynamic Small Business Search registry. Proprietary information should be clearly labeled, but the government assumes no liability for its protection. No questions will be answered in connection with this notice, and responses received will be used solely for acquisition planning purposes.